The U.S. Food and Drug Administration (FDA) has approved the first two tests for coronavirus this Friday that measure a person’s antibody levels and not just determine whether they have them or not.
“The ability to measure a patient’s relative antibody level in response to a previous SARS-CoV-2 infection could be helpful as we learn more about the virus and the importance of antibodies,” said the director. from the FDA Office for In Vitro Diagnostics and Radiological Health, Tim Stenzel.
The new tests that have been approved provide information about the body’s immune response to the virus and are not based solely on virus detection.
“There are still a lot of unknowns about what the presence of virus antibodies can say about potential immunity, but today’s approvals provide us with additional tools to evaluate these antibodies when we examine and examine the virus,” added Stenzel. It is a statement.